Skip to main content
Erschienen in: European Journal of Medical Research 1/2023

Open Access 01.12.2023 | Research

The cause and effect of gut microbiota in development of inflammatory disorders of the breast

verfasst von: Yibo Gu, Muye Hou, Jinyu Chu, Li Wan, Muyi Yang, Jiemiao Shen, Minghui Ji

Erschienen in: European Journal of Medical Research | Ausgabe 1/2023

Abstract

Background

Inflammatory disorders of the breast (IDB) damages the interests of women and children and hinders the progress of global health seriously. Several studies had offered clues between gut microbiota (GM) and inflammatory disorders of the breast (IDB). The gut–mammary gland axis also implied a possible contribution of the GM to IDB. However, the causality between them is still elusive.

Methods

The data of two-sample Mendelian randomization (MR) study related to the composition of GM (n = 18,340) and IDB (n = 177,446) were accessed from openly available genome-wide association studies (GWAS) database. As the major analytical method, inverse variance weighted (IVW) was introduced and several sensitive analytical methods were conducted to verify results.

Results

Inverse variance weighted revealed Eubacterium rectale group (OR = 1.87, 95% CI: 1.02–3.43, p = 4.20E−02), Olsenella (OR = 1.29, 95% CI: 1.02–1.64, p = 3.30E−02), Ruminiclostridium-6 (OR = 1.53, 95% CI: 1.08–2.14, p = 1.60E−02) had an anti-protective effect on IDB. Peptococcus (OR = 0.75, 95% CI: 0.60–0.94, p = 1.30E−02) had a protective effect on IDB. The results were credible through a series of test.

Conclusions

We revealed causality between IDB and GM taxa, exactly including Ruminiclostridium-6, Eubacterium rectale group, Olsenella and Peptococcus. These genera may become novel biomarkers and supply new viewpoint for probiotic treatment. However, these findings warrant further test owing to the insufficient evidences.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s40001-023-01281-6.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
IDB
Inflammatory disorders of the breast
LM
Lactational mastitis
NLM
Non-lactational mastitis
GM
Gut microbiota
MR
Mendelian randomization
GWAS
Genome-wide association studies
SNPs
Single nucleotide polymorphisms
IVW
Inverse variance weighted
FMT
Feces microbiota transplantation
RCTs
Randomized controlled trials
IVs
Instrumental variables
SCFAs
Short chain fatty acid

Background

Inflammatory disorders of the breast (IDB) could be categorized into lactational mastitis (LM) and non-lactational mastitis (NLM) according to the time of occurrence [1]. The reported incidence has shown the IDB ranges from 3 to 33% of women in lactation period, and less than 10% in non-lactating ones [2, 3]. Whether LM or NLM, to resist distinct clinical manifestations of localized and associated systemic symptoms, women commonly adopt antibiotic therapy [4, 5]. Delayed treatment may cause severe outcomes such as sepsis for LM and breast fistula for NLM. Breast abscess is also a potential complication for IDB [6]. Due to the long treatment duration, ineffective adopting antibiotic and easy recurrence, the treatment of NLM faces tremendous challenge [7, 8], which may result in considerable economic burden and psychological distress in women. In addition, breastfeeding is utmost important and is considered as the origin of life. The beginning and development of LM may cause premature cessation of breastfeeding, suffering to both mothers and children [9]. Despite routine treatment including antibiotic has been used extensively, the effectiveness and security of antibiotic therapy has not been confirmed yet [8, 10, 11]. Thus, it is crucial to clarify the etiology of IDB and to prevent the occurrence of IDB from its root causes. However, tangible etiology concerning IDB remains unclear due to research deficiency [12, 13]. Therefore, considering the benefits of health and current treatments are not all effective, it is imperative to seek the etiology of IDB.
The GM, familiar with the "second genome of the human", is tightly linked to our benefits and disorders [14]. Due to the presence of gut–mammary gland axis, gut dysbiosis may contribute to the occurrence and development of breast disorders [15, 16]. Animal studies have proven disturbance of GM and related metabolites induced the development of IDB in mice [17], and feces microbiota transplantation (FMT) could reverse adverse effects [18]. Microbiota-depleted mice developed IDB symptoms when were transplanted with the GM from unhealthy cows with IDB [19]. Nevertheless, the evidence of randomized controlled trials (RCTs) between IDB and GM is scanty and has not been fully evaluated [20]. In addition, observational studies of GM and IDB are vulnerable to external factors such as genotyping of gut microbial community, dietary appetite, mood and life mode [21, 22]. It is unknown whether the specific taxa of GM cause IDB or not. Therefore, it is urgent to confirm causality of GM on IDB and to understand which microbiota taxa developing IDB.
Due to limitations of medical ethics and high costs, some RCTs are difficult to carry out in practical work [23]. MR study was introduced to exploit in the inference of epidemiological causes. Based on Mendel's Laws of Inheritance, MR could progress causal inference among exposure and outcome [24]. Mounting MR analysis has been introduced to confirm the causality between GM and disorders, by way of example, cancers [25], cardiovascular diseases [26] and depressive disorder [27]. In this study, MiBioGen and FinnGen consortiums, two large GWAS databases, were employed for statistical analysis. A two-sample MR design was conducted to verify causality and to provide a theoretical foundation for the etiology and biomarker of IDB.

Methods

The assumptions and study design of MR

The diagrammatic sketch of this research is illustrated in Fig. 1. Briefly, the exposure is the GM, whereas the outcome is IDB. Moreover, reliable results are based on the following 3 assumptions of MR analysis [28]: (1) the closely relationship between the instrumental variables (IVs) and exposure should be a must; (2) IVs should be independent, ensuring no relation with confounding factors; (3) IVs influenced outcome through exposure rather than other factors.

Data sources

This research related summary-level data were downloaded from openly GWAS database. In detail, the GWAS data on GM originated from MiBioGen consortium [2931] and the GWAS data relating IDB were mainly conducted by the Finngen consortium [32, 33]. Ethical approval and consent of GWAS database were achieved, and the summary-level data were publicly available and could be used.
MiBioGen consortium included 24 large cohorts (18,340 participants) from most European countries. 16S rRNA sequencing was used to explore composition of microbial communities and its classification via microbial classification standards [34]. 122,110 variant sites from 211 taxa were obtain in microbiota-GWAS. Owing to 12 unknown genera and 3 unknown families, a total of 196 taxa were included for analysis in the end. In our study, we selected IVs from genus to phylum level of GM taxa. For more detailed information, please refer to original articles [29]. According to the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), this phenotype is “inflammatory disorders of the breast” (ICD-10 code N61). IDB is defined as the inflammation of breast tissue during lactation or postpartum due to an obstructed duct or infection. IDB can also occur in non-breastfeeding women, and rarely in men. We use this phenotype for the following reasons: firstly, enough types of relating diseases: this phenotype excludes neonatal infective mastitis, includes (1) acute, chronic and nonpuerperal abscess of areola and breast; (2) carbuncle of breast; (3) acute, subacute and nonpuerperal mastitis. Secondly, profound impacts of relating diseases: we have ploughed through relating documents that whatever disease which leading to the inflammation of breast tissue may result in the interruption of lactation and have impact on mother and children health [35, 36]. Therefore, once women develop IDB, this adverse state could inevitably affect women themselves and if women were in lactation period, it could bring breastfeeding crisis. Thirdly, this consortium was large enough to explore the causality between GM and IDB. Above all, we introduced this consortium. A total of 177,446 participants were involved in this GWAS. Among this GWAS, it recruited 177,446 female subjects and divided into 1435 cases and 176,011 controls. A series of corrections have been made during the performance [32].

Instrumental variables (IVs)

The selection criteria of IVs were following: (1) previous articles were referred to formulate a relatively more wide-ranging principle (p < 1 × 10–5) [37, 38]. Therefore, p < 1 × 10–5 was performed because of the less eligible IVs (p < 5 × 10–8) [39, 40]. (2) 1000 Genomes project European samples data were referenced to compute the linkage disequilibrium (LD) (R2 < 0.001, clumping distance = 10,000 kb) between the single nucleotide polymorphisms (SNPs), these SNPs with the lowest P-values would be eventually reserved. (3) Under the presence of palindromic SNPs circumstances, we used allele frequencies to infer positive strand alleles. (4) During the comparing process, we checked the alleles against Genome Reference Consortium Human Build 38 and removed indeterminate and duplicated SNPs.

Statistical analysis

R software (Version 4.1.0) and R package TwosampleMR (Version 0.56) were performed to this statistical analysis. We carried out p < 0.05, a threshold of statistical significance, as a potential causal effect.
During this statistical analysis, several methods were performed to determine the causality between GM and IDB. IVW is a meta-analysis method used by MR to analyze the effects of multiple SNPs at multiple loci. The application premise of IVW is that all SNPs are valid IVs and completely independent of each other. Based on this, the unbiased of IVW results would be presented [41]. MR-Egger regression does not force the regression line to pass through the origin, allowing for targeted gene pleiotropy in the included instrumental variables. When the regression intercept is not zero and p for intercept < 0.05, it indicates the existence of gene pleiotropy [42]. The weighted median is the median of the distribution function obtained after all individual SNP effect size are sorted by weight. When at least 50% of the information comes from effective instrumental variables, weighted median can obtain robust estimates [43]. MR-PRESSO is a method of evaluating horizontal polymorphism using whole genome aggregated association statistical data. MR-PRESSO has three components, including MR-PRESSO overall test, MR-PRESSO outlier test and MR-PRESSO distortion test. Specific SNPs can be excluded by excluding outlier to obtain an estimate closer to the true value [44]. The weighted model and simple model also used to evaluate the effectiveness and correctness of MR calculations [45]. The simple mode takes the largest cluster of SNPs’ causal estimation, and the weighted mode assigns the weights to each SNP [46]. Finally, Cochran's Q statistic was applied to detect heterogeneity. If the Cochran's Q statistic test has statistical significance, it proves that the results were significant heterogeneity.
The leave-one-out method refers to omitting each SNP in turn, calculating the meta effect of the remaining SNPs, and observing whether the results have changed after removing each SNP. If the results change significantly after removing a certain SNP, it indicates that the potential heterogeneous SNPs have a significant impact on the results [47].
The scatter plot is a plot where the effect of the same SNP on exposure is placed on the horizontal axis, the effect on outcome is placed on the vertical axis, and the slope of the plot represents the causal effect of exposure factors on outcomes. It could visualize the causal effect of exposure on outcomes estimated under different parameter estimation methods [48].
To avoid weak instrument bias, the robustness of IVs could be assessed through F-statistic. We adopt formula F = \(\frac{{R}^{2}\times (N-2)}{(1-{R}^{2})}\) to calculate F-statistic. Among which, we could use R2 to represent the degree of exposure explained by IVs with the formula R2 = \(\frac{(2\times EAF\times (1 - EAF)\times {beta}^{2})}{(2\times EAF\times (1 - EAF) \times {beta}^{2}) + (2\times EAF\times (1 - EAF)\times N\times SE{(beta)}^{2}},\) where EAF represents the effect allele frequency, beta represents the effect estimate of the genetic variant in the exposure GWAS, SE(beta) represents the standard error of the beta and N represents sample size [46, 49, 50]. In general, when the corresponding F-statistic was > 10, significant weak instrumental bias could be reduced [51].
In the reverse MR analysis, the exposure is the IDB, whereas the outcome is GM. We selected IVs for each IDB phenotypes by using a much stricter threshold, where the significant threshold (p < 5 × 10–8) [52, 53]. Additionally, the phenotypes, methods and other settings were consistent with those of forward MR. Under the significant threshold (p < 5 × 10–8), no eligible SNP as IV was selected. A reverse MR analysis was not conducted at last owing to lack of SNPs (related to IDB) satisfying the assumption of the MR study.

Results

Selection of IVs

Based on the previous selection criteria of IVs (p < 1 × 10–5), a total of 2370 SNPs were anchored as IVs related to bacterial taxa from phylum to genus for IDB. For further information, Additional file 1: Table S1 is provided for reference.

Causal effect of GM on IDB

As shown in Table 1, seven bacterial genera including Eubacterium rectale group, Bifidobacterium, Olsenella, Peptococcus, Prevotella7, Ruminiclostridium-6, RuminococcaceaeUCG003 were found to be associated with IDB in at least one MR method. MR methods found no relevance between bacterial taxa from phylum to family for IDB and detailed results are shown in Additional file 1: Table S2. Among seven bacterial genera, Eubacterium rectale group, Olsenella, Peptococcus and Ruminiclostridium-6 were supported by IVW analysis. Specifically, Eubacterium rectale group (OR = 1.87, 95% CI: 1.02–3.43, p = 4.20E−02), Olsenella (OR = 1.29, 95% CI: 1.02–1.64, p = 3.30E−02), Ruminiclostridium-6 (OR = 1.53, 95% CI: 1.08–2.14, p = 1.60E−02) had an anti-protective effect on IDB. Peptococcus (OR = 0.75, 95% CI: 0.60–0.94, p = 1.30E−02) had a protective effect on IDB. In addition, the F-statistics of seven bacterial genera selected at least one MR method were all above 10, eliminating the possibility of weak instrument bias (more detailed results are shown in Additional file 1: Table S3).
Table 1
MR estimates for the association between gut microbiota and IDB
Exposure
Method
No. of SNP
F-statistic
OR
95%CI
p-value
Eubacterium rectale group
MR Egger
7
213.61
2.18
0.22–21.47
0.53
 
Weighted median
7
 
1.48
0.72–3.06
0.28
 
IVW
7
 
1.87
1.02–3.43
4.20E−02
 
Simple mode
7
 
1.11
0.39–3.19
0.85
 
Weighted mode
7
 
1.22
0.47–3.16
0.7
Bifidobacterium
MR Egger
19
611.71
0.38
0.17–0.83
2.70E−02
 
Weighted median
19
 
0.95
0.66–1.37
0.79
 
IVW
19
 
0.98
0.71–1.34
0.88
 
Simple mode
19
 
1.24
0.65–2.37
0.52
 
Weighted mode
19
 
1.02
0.63–1.65
0.94
Olsenella
MR Egger
9
191.85
1.36
0.48–3.85
0.58
 
Weighted median
9
 
1.34
0.99–1.81
0.06
 
IVW
9
 
1.29
1.02–1.64
3.30E−02
 
Simple mode
9
 
1.48
0.93–2.37
0.14
 
Weighted mode
9
 
1.49
0.93–2.38
0.14
Peptococcus
MR Egger
13
387.2
0.70
0.26–1.84
0.48
 
Weighted median
13
 
0.81
0.59–1.11
0.19
 
IVW
13
 
0.75
0.60–0.94
1.30E−02
 
Simple mode
13
 
0.81
0.49–1.36
0.45
 
Weighted mode
13
 
0.83
0.51–1.34
0.45
Prevotella7
MR Egger
11
249.45
1.02
0.18–5.71
0.98
 
Weighted median
11
 
1.38
1.01–1.89
4.60E−02
 
IVW
11
 
1.17
0.89–1.56
0.26
 
Simple mode
11
 
1.54
0.83–2.85
0.2
 
Weighted mode
11
 
1.52
0.82–2.82
0.22
Ruminiclostridium-6
MR Egger
14
314.03
1.27
0.54–2.98
0.59
 
Weighted median
14
 
1.62
1.00–2.65
0.05
 
IVW
14
 
1.53
1.08–2.17
1.60E−02
 
Simple mode
14
 
1.58
0.74–3.36
0.25
 
Weighted mode
14
 
1.63
0.86–3.10
0.16
Ruminococcaceae UCG003
MR Egger
10
268.82
2.87
0.78–10.57
0.15
 
Weighted median
10
 
1.79
1.04–3.07
3.40E−02
 
IVW
10
 
1.40
0.92–2.15
0.12
 
Simple mode
10
 
2.04
0.89–4.65
0.13
 
Weighted mode
10
 
2.08
0.94–4.61
0.11
IDB inflammatory disorders of the breast, GM gut microbiota, SNP single nucleotide polymorphism, OR odds ratio, CI confidence interval, IVW inverse variance weighted, MR Mendelian randomization

Sensitivity analysis

As displayed in Additional file 1: Table S4, sensitivity analysis was employed to identify the pleiotropy and heterogeneity. The results obtained by MR-Egger regression were as follows: Eubacterium rectale group (p = 0.90), Olsenella (p = 0.93), Peptococcus (p = 0.88), Ruminiclostridium-6 (p = 0.65), Prevotella7 (p = 0.87) and RuminococcaceaeUCG003 (p = 0.29), these six bacterial genera showed no horizontal pleiotropy. However, Bifidobacterium (p = 0.02) was removed due to the existence of pleiotropy (Table 2). Meanwhile, Cochran’s IVW Q test suggested Eubacterium rectale group (IVW: p = 0.23; MR Egger: p = 0.15), Olsenella (IVW: p = 0.87; MR Egger: p = 0.80), Peptococcus (IVW: p = 0.92; MR Egger: p = 0.88), Ruminiclostridium-6 (IVW: p = 0.76; MR Egger: p = 0.71) and RuminococcaceaeUCG003 (IVW: p = 0.28; MR Egger: p = 0.31) had no significant heterogeneity except Prevotella7 (IVW: p = 0.04; MR Egger: p = 0.03) (Table 2). Interestingly, although no significant pleiotropy and heterogeneity has been founded in RuminococcaceaeUCG003, RuminococcaceaeUCG003 was still filtered out under the IVW results (p = 0.12).
Table 2
Sensitivity analysis between gut microbiota and IDB
Exposure
Method
Q
Q_pval
MR Egger
intercept
MR Egger
pval
MR PRESSO
pval
Eubacterium rectale group
MR Egger
8.04
0.15
− 0.01
0.90
0.27
IVW
8.07
0.23
Bifidobacterium
MR Egger
19.68
0.29
0.08
0.02
0.07
 
IVW
27.05
0.08
Olsenella
MR Egger
3.84
0.80
− 0.01
0.93
0.87
 
IVW
3.84
0.87
Peptococcus
MR Egger
5.96
0.88
0.01
0.88
0.94
 
IVW
5.99
0.92
Prevotella7
MR Egger
18.61
0.03
0.02
0.87
0.06
 
IVW
18.67
0.04
Ruminiclostridium-6
MR Egger
8.91
0.71
0.02
0.65
0.80
 
IVW
9.13
0.76
RuminococcaceaeUCG003
MR Egger
9.42
0.31
− 0.06
0.29
0.31
 
IVW
10.94
0.28
IDB inflammatory disorders of the breast, GM gut microbiota, IVW inverse-variance weighted, MR Mendelian randomization
The leave-one-out plots (Fig. 2) and the scatter plots (Fig. 3) have shown the possible presence of potential outliers. In order to pursue the robustness of MR-Egger regression results, the method of MR-PRESSO method was used. The results were optimistic as no significant outliers were found (all p > 0.05, Table 2).
Finally, the main point is that the outcomes of IVW were assured after checking heterogeneity and pleiotropy. Therefore, Eubacterium rectale group, Olsenella, Peptococcus and Ruminiclostridium-6 were causally related to IDB.

Discussion

As far as we know, our study takes the lead in assessing the causality between GM and IDB in terms of the genetic level. In this study, two-sample MR analysis based on the largest GWAS data set gave fairly strong evidence that gut microbiome plays non-negligible role in the occurrence and progression of IDB, in which, metabolites may be involved in. Results displayed that Eubacterium rectale group, Olsenella and Ruminiclostridium-6 had an anti-protective effect on IDB, whereas Peptococcus had a protective effect on IDB.
Several studies have reported the association between Ruminiclostridium-6 and other disorders, although the relationship between Ruminiclostridium-6 and IDB has not been explored. Previous studies revealed that Ruminiclostridium-6 acted as a vital regulatory effect in colitis. Ruminiclostridium-6 could contribute to the release of proinflammatory factors such as IL-6, IL-1β, TNF-α and IL-8 and deteriorate colitis [54]. In addition, a cohort study has shown the Ruminiclostridium-6 was significantly enriched in community-acquired pneumonia patients, implying its potential pathogenicity [55]. IDB is an infection of mammary gland [56] that may be due to a severe disruption of the blood–milk barrier [57] caused by harmful factors (e.g., enteropathogenic bacteria), which in turn is transferred from the intestine to the breast. Current evidence focuses on the pathogenesis of rumen-induced IDB. Rumen-derived LPS decreased the expression of tight junctional proteins, in turn disrupts the blood–milk barrier and increasing permeability. Therefore, we hypothesized that Ruminiclostridium-6 may have a performance impact on IDB via regulating proinflammatory factors to disrupt the blood–milk barrier and deteriorate IDB.
Conclusive evidence also needed to confirm how Eubacterium rectale group and Olsenella increase the risk of IDB. Although Eubacterium rectale group as one of butyrate-producing flora benefits to certain disorder [58], butyrate is also reported to promote tumorigenesis [59]. The evidence against Eubacterium rectale group have been documented. Islam et al has found Eubacterium rectale group inhibited CD83 to keep mice in systemic inflammation [60]. Wang et al. also revealed the Eubacterium rectale group played proinflammatory role in colorectal cancer [61]. Therefore, we could infer a conclusion that Eubacterium rectale group exacerbates IDB through systemic inflammation. For Olsenella, only observational study has reported its changes with disease [62, 63]. Our study verified the potential harmfulness of Olsenella in humans at the first time and Olsenella has the potential to be a candidate of biomarker of IDB.
Trillions of symbiotic GM on the surface of the human gastrointestinal mucosa maintain the host health. As the degree of IDB increased, short chain fatty acids (SCFAs) were significantly decreased [64]. A strategy of probiotics treatment may reduce the risk [65]. Peptococcus has a solid positive correlation with valeric acid and butyrate [6668]. Probiotics and SCFAs may inhibit inflammation and maintain blood–milk barrier function. Research revealed SCFAs participated in the energy supply of tight junction proteins [69], suggesting its function in the developing of blood–milk barrier. Propionate acid shielded lactating women from IDB by modulating the blood–milk barrier [70]. The research also pointed that butyrate, one of SCFAs, was at dominance of modulating the inflammatory response [18, 71]. Moreover, butyrate repairs blood–milk barrier by improving tight junction proteins [72]. Although few reports concentrated on Peptococcus acting as a probiotic in the past, our study has found Peptococcus may become a candidate of probiotics therapy today. Nevertheless, more RCTs are needed to conduct to support the novel treatment.
This research has several advantages. Genetic variation is not affected by confounding factors. Thus, the measurement error between genetic variation and its effects is relatively small. Based on this, we employed MR analysis to determine the causal effect between GM and IDB. Genetic data were adopted from the latest large GWAS, keeping the robustness of IVs in the MR analysis. Several statistical techniques were performed to detect the precision of results. A two-sample MR design widely used because it avoids bias by nonoverlapping data.
However, several limitations in this study deserve noting. Firstly, weak instrumental bias may not be avoided even if satisfying the MR assumptions (IVs are closely correlated with GM taxa). Secondly, the GWAS recruited subjects only of particular race or nationality, the generalization of findings in our research could not be suitable. MR studies of cross racial may consider for better generalizability. Thirdly, MR analysis typically reveals a lifetime exposure, the existence of canalization may cause overestimation of effect size. Further RCTs should be performed to exam the effect. Fourthly, we conducted MR analysis on five species level, however, we only found eligible SNPs on genus level, thus we could try our best to enlarge the sample size to improve the effectiveness of samples. Finally, the research of biological mechanisms should be paid attention to interpret MR results.

Conclusions

In summary, we revealed causality between IDB and GM taxa, exactly including Ruminiclostridium-6, Eubacterium rectale group, Olsenella and Peptococcus. These genera may become novel biomarkers and supply new viewpoint for probiotic treatment. However, these findings warrant further testing owing to the insufficient evidences.

Acknowledgements

It is my great appreciated that two large GWAS database include MiBioGen and FinnGen consortium for sharing research results data. We are also deeply grateful to all of subjects and investigators involved in FinnGen and MiBioGen study.

Declarations

This article related summary statistics all adopted from published available data. Ethical approval and consent of database were achieved. Extra individual-level data were not introduced into this study, so additional ethics approval was not needed.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Scott DM. Inflammatory diseases of the breast. Best Pract Res Clin Obstet Gynaecol. 2022;83:72–87.PubMedCrossRef Scott DM. Inflammatory diseases of the breast. Best Pract Res Clin Obstet Gynaecol. 2022;83:72–87.PubMedCrossRef
2.
Zurück zum Zitat Lai BY, Yu BW, Chu AJ, et al. Risk factors for lactation mastitis in China: a systematic review and meta-analysis. PLoS ONE. 2021;16(5): e0251182.PubMedPubMedCentralCrossRef Lai BY, Yu BW, Chu AJ, et al. Risk factors for lactation mastitis in China: a systematic review and meta-analysis. PLoS ONE. 2021;16(5): e0251182.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Kamal RM, Hamed ST, Salem DS. Classification of inflammatory breast disorders and step by step diagnosis. Breast J. 2009;15(4):367–80.PubMedCrossRef Kamal RM, Hamed ST, Salem DS. Classification of inflammatory breast disorders and step by step diagnosis. Breast J. 2009;15(4):367–80.PubMedCrossRef
4.
Zurück zum Zitat Blackmon MM, Nguyen H, Mukherji P. Acute mastitis. StatPearls, Treasure Island (FL): StatPearls Publishing; 2023. Blackmon MM, Nguyen H, Mukherji P. Acute mastitis. StatPearls, Treasure Island (FL): StatPearls Publishing; 2023.
5.
Zurück zum Zitat Tsai MJ, Huang WC, Wang JT, et al. Factors associated with treatment duration and recurrence rate of complicated mastitis. J Microbiol Immunol Infect. 2020;53(6):875–81.PubMedCrossRef Tsai MJ, Huang WC, Wang JT, et al. Factors associated with treatment duration and recurrence rate of complicated mastitis. J Microbiol Immunol Infect. 2020;53(6):875–81.PubMedCrossRef
6.
Zurück zum Zitat Kataria N, Lam DL, Parker EU. Radiology-pathology correlation: inflammatory conditions of the breast. Curr Breast Cancer Rep. 2021;13(4):282–95.CrossRef Kataria N, Lam DL, Parker EU. Radiology-pathology correlation: inflammatory conditions of the breast. Curr Breast Cancer Rep. 2021;13(4):282–95.CrossRef
7.
Zurück zum Zitat Gopalakrishnan Nair C, Hiran JP, et al. Inflammatory diseases of the non-lactating female breasts. Int J Surg. 2015;13:8–11.PubMedCrossRef Gopalakrishnan Nair C, Hiran JP, et al. Inflammatory diseases of the non-lactating female breasts. Int J Surg. 2015;13:8–11.PubMedCrossRef
10.
Zurück zum Zitat Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Sao Paulo Med J. 2016;134(3):273.PubMedCrossRef Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Sao Paulo Med J. 2016;134(3):273.PubMedCrossRef
11.
Zurück zum Zitat Anderson PO. Guidelines for reporting cases of medication use during lactation. Breastfeed Med. 2022;17(2):93–7.PubMedCrossRef Anderson PO. Guidelines for reporting cases of medication use during lactation. Breastfeed Med. 2022;17(2):93–7.PubMedCrossRef
12.
Zurück zum Zitat Costa Morais Oliveira V, Cubas-Vega N, López Del-Tejo P, et al. Non-lactational infectious mastitis in the Americas: a systematic review. Front Med (Lausanne). 2021;8: 672513.PubMedPubMedCentralCrossRef Costa Morais Oliveira V, Cubas-Vega N, López Del-Tejo P, et al. Non-lactational infectious mastitis in the Americas: a systematic review. Front Med (Lausanne). 2021;8: 672513.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Patel SH, Vaidya YH, Patel RJ, et al. Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep. 2017;7(1):7804.PubMedPubMedCentralCrossRef Patel SH, Vaidya YH, Patel RJ, et al. Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep. 2017;7(1):7804.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Yue Q, Cai M, Xiao B, et al. The microbiota-gut-brain axis and epilepsy. Cell Mol Neurobiol. 2022;42(2):439–53.PubMedCrossRef Yue Q, Cai M, Xiao B, et al. The microbiota-gut-brain axis and epilepsy. Cell Mol Neurobiol. 2022;42(2):439–53.PubMedCrossRef
15.
Zurück zum Zitat Hu X, He Z, Zhao C, et al. Gut/rumen-mammary gland axis in mastitis: gut/rumen microbiota-mediated “gastroenterogenic mastitis.” J Adv Res. 2023;S2090–1232(23):00060–7. Hu X, He Z, Zhao C, et al. Gut/rumen-mammary gland axis in mastitis: gut/rumen microbiota-mediated “gastroenterogenic mastitis.” J Adv Res. 2023;S2090–1232(23):00060–7.
17.
Zurück zum Zitat Zhao C, Hu X, Bao L, et al. Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice. PLoS Pathog. 2021;17(7): e1009774.PubMedPubMedCentralCrossRef Zhao C, Hu X, Bao L, et al. Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice. PLoS Pathog. 2021;17(7): e1009774.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Hu X, Guo J, Zhao C, et al. The gut microbiota contributes to the development of Staphylococcus aureus-induced mastitis in mice. ISME J. 2020;14(7):1897–910.PubMedPubMedCentralCrossRef Hu X, Guo J, Zhao C, et al. The gut microbiota contributes to the development of Staphylococcus aureus-induced mastitis in mice. ISME J. 2020;14(7):1897–910.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Ma C, Sun Z, Zeng B, et al. Cow-to-mouse fecal transplantations suggest intestinal microbiome as one cause of mastitis. Microbiome. 2018;6(1):200.PubMedPubMedCentralCrossRef Ma C, Sun Z, Zeng B, et al. Cow-to-mouse fecal transplantations suggest intestinal microbiome as one cause of mastitis. Microbiome. 2018;6(1):200.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Crepinsek MA, Taylor EA, Michener K, et al. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev. 2020;9(9): Cd007239.PubMed Crepinsek MA, Taylor EA, Michener K, et al. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev. 2020;9(9): Cd007239.PubMed
21.
Zurück zum Zitat Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160(5):1486–501.PubMedCrossRef Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160(5):1486–501.PubMedCrossRef
23.
Zurück zum Zitat Wang YZ, Shen HB. Challenges and factors that influencing causal inference and interpretation, based on Mendelian randomization studies. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(8):1231–6.PubMed Wang YZ, Shen HB. Challenges and factors that influencing causal inference and interpretation, based on Mendelian randomization studies. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(8):1231–6.PubMed
25.
Zurück zum Zitat Long Y, Tang L, Zhou Y, et al. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med. 2023;21(1):66.PubMedPubMedCentralCrossRef Long Y, Tang L, Zhou Y, et al. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med. 2023;21(1):66.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Zhang Y, Zhang X, Chen D, et al. Causal associations between gut microbiome and cardiovascular disease: a Mendelian randomization study. Front Cardiovasc Med. 2022;9: 971376.PubMedPubMedCentralCrossRef Zhang Y, Zhang X, Chen D, et al. Causal associations between gut microbiome and cardiovascular disease: a Mendelian randomization study. Front Cardiovasc Med. 2022;9: 971376.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Chen M, Xie CR, Shi YZ, et al. Gut microbiota and major depressive disorder: a bidirectional Mendelian randomization. J Affect Disord. 2022;316:187–93.PubMedCrossRef Chen M, Xie CR, Shi YZ, et al. Gut microbiota and major depressive disorder: a bidirectional Mendelian randomization. J Affect Disord. 2022;316:187–93.PubMedCrossRef
28.
Zurück zum Zitat de Leeuw CA, Savage JE, Bucur IG, et al. Understanding the assumptions underlying Mendelian randomization. Eur J Hum Genet. 2021;30:653–60.CrossRef de Leeuw CA, Savage JE, Bucur IG, et al. Understanding the assumptions underlying Mendelian randomization. Eur J Hum Genet. 2021;30:653–60.CrossRef
29.
Zurück zum Zitat Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156–65.PubMedPubMedCentralCrossRef Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156–65.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Wray NR, Ripke S, Mattheisen M, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668–81.PubMedPubMedCentralCrossRef Wray NR, Ripke S, Mattheisen M, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668–81.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Kurki MI KJ, Palta P, Sipilä TP, Kristiansson K, Donner K, et al. . FinnGen: unique genetic insights from combining isolated population and national health register data, 2022.03.03.22271360. Kurki MI KJ, Palta P, Sipilä TP, Kristiansson K, Donner K, et al. . FinnGen: unique genetic insights from combining isolated population and national health register data, 2022.03.03.22271360.
34.
Zurück zum Zitat Wang J, Kurilshikov A, Radjabzadeh D, et al. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative. Microbiome. 2018;6(1):101.PubMedPubMedCentralCrossRef Wang J, Kurilshikov A, Radjabzadeh D, et al. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative. Microbiome. 2018;6(1):101.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Angelopoulou A, Field D, Ryan CA, et al. The microbiology and treatment of human mastitis. Med Microbiol Immunol. 2018;207(2):83–94.PubMedCrossRef Angelopoulou A, Field D, Ryan CA, et al. The microbiology and treatment of human mastitis. Med Microbiol Immunol. 2018;207(2):83–94.PubMedCrossRef
36.
Zurück zum Zitat Kornfeld HW, Mitchell KB. Management of idiopathic granulomatous mastitis in lactation: case report and review of the literature. Int Breastfeed J. 2021;16(1):23.PubMedPubMedCentralCrossRef Kornfeld HW, Mitchell KB. Management of idiopathic granulomatous mastitis in lactation: case report and review of the literature. Int Breastfeed J. 2021;16(1):23.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Li P, Wang H, Guo L, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med. 2022;20(1):443.PubMedPubMedCentralCrossRef Li P, Wang H, Guo L, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med. 2022;20(1):443.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Liu K, Zou J, Fan H, et al. Causal effects of gut microbiota on diabetic retinopathy: a Mendelian randomization study. Front Immunol. 2022;13: 930318.PubMedPubMedCentralCrossRef Liu K, Zou J, Fan H, et al. Causal effects of gut microbiota on diabetic retinopathy: a Mendelian randomization study. Front Immunol. 2022;13: 930318.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600–5.PubMedPubMedCentralCrossRef Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51(4):600–5.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Jia J, Dou P, Gao M, et al. Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional mendelian randomization analysis. Diabetes. 2019;68(9):1747–55.PubMedCrossRef Jia J, Dou P, Gao M, et al. Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional mendelian randomization analysis. Diabetes. 2019;68(9):1747–55.PubMedCrossRef
41.
Zurück zum Zitat Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880–906.PubMedCrossRef Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880–906.PubMedCrossRef
42.
Zurück zum Zitat Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.PubMedPubMedCentralCrossRef Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.PubMedPubMedCentralCrossRef Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.PubMedPubMedCentralCrossRef Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Lin L, Luo P, Yang M, et al. Causal relationship between osteoporosis and osteoarthritis: a two-sample Mendelian randomized study. Front Endocrinol (Lausanne). 2022;13:1011246.PubMedCrossRef Lin L, Luo P, Yang M, et al. Causal relationship between osteoporosis and osteoarthritis: a two-sample Mendelian randomized study. Front Endocrinol (Lausanne). 2022;13:1011246.PubMedCrossRef
46.
Zurück zum Zitat Gao Y, Fan ZR, Shi FY. Hypothyroidism and rheumatoid arthritis: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1179656.PubMedCrossRef Gao Y, Fan ZR, Shi FY. Hypothyroidism and rheumatoid arthritis: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1179656.PubMedCrossRef
49.
Zurück zum Zitat Levin MG, Judy R, Gill D, et al. Genetics of height and risk of atrial fibrillation: a Mendelian randomization study. PLoS Med. 2020;17(10): e1003288.PubMedPubMedCentralCrossRef Levin MG, Judy R, Gill D, et al. Genetics of height and risk of atrial fibrillation: a Mendelian randomization study. PLoS Med. 2020;17(10): e1003288.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Shi J, Tian J, Fan Y, et al. Intelligence, education level, and risk of Parkinson’s disease in European populations: a Mendelian randomization study. Front Genet. 2022;13: 963163.PubMedPubMedCentralCrossRef Shi J, Tian J, Fan Y, et al. Intelligence, education level, and risk of Parkinson’s disease in European populations: a Mendelian randomization study. Front Genet. 2022;13: 963163.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica. 1997;65(3):557–86.CrossRef Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica. 1997;65(3):557–86.CrossRef
52.
Zurück zum Zitat Yu XH, Yang YQ, Cao RR, et al. The causal role of gut microbiota in development of osteoarthritis. Osteoarthr Cartil. 2021;29(12):1741–50.CrossRef Yu XH, Yang YQ, Cao RR, et al. The causal role of gut microbiota in development of osteoarthritis. Osteoarthr Cartil. 2021;29(12):1741–50.CrossRef
53.
Zurück zum Zitat Liu B, Ye D, Yang H, et al. Two-sample Mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative colitis or Crohn’s disease. Front Immunol. 2022;13: 921546.PubMedPubMedCentralCrossRef Liu B, Ye D, Yang H, et al. Two-sample Mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative colitis or Crohn’s disease. Front Immunol. 2022;13: 921546.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Ge H, Cai Z, Chai J, et al. Egg white peptides ameliorate dextran sulfate sodium-induced acute colitis symptoms by inhibiting the production of pro-inflammatory cytokines and modulation of gut microbiota composition. Food Chem. 2021;360: 129981.PubMedCrossRef Ge H, Cai Z, Chai J, et al. Egg white peptides ameliorate dextran sulfate sodium-induced acute colitis symptoms by inhibiting the production of pro-inflammatory cytokines and modulation of gut microbiota composition. Food Chem. 2021;360: 129981.PubMedCrossRef
55.
Zurück zum Zitat Xiao Q, Tan S, Liu C, et al. Characterization of the microbiome and host’s metabolites of the lower respiratory tract during acute community-acquired pneumonia identifies potential novel markers. Infect Drug Resist. 2023;16:581–94.PubMedPubMedCentralCrossRef Xiao Q, Tan S, Liu C, et al. Characterization of the microbiome and host’s metabolites of the lower respiratory tract during acute community-acquired pneumonia identifies potential novel markers. Infect Drug Resist. 2023;16:581–94.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Omranipour R, Vasigh M. Mastitis, breast abscess, and granulomatous mastitis. Adv Exp Med Biol. 2020;1252:53–61.PubMedCrossRef Omranipour R, Vasigh M. Mastitis, breast abscess, and granulomatous mastitis. Adv Exp Med Biol. 2020;1252:53–61.PubMedCrossRef
57.
Zurück zum Zitat Wall SK, Hernández-Castellano LE, Ahmadpour A, et al. Differential glucocorticoid-induced closure of the blood-milk barrier during lipopolysaccharide- and lipoteichoic acid-induced mastitis in dairy cows. J Dairy Sci. 2016;99(9):7544–53.PubMedCrossRef Wall SK, Hernández-Castellano LE, Ahmadpour A, et al. Differential glucocorticoid-induced closure of the blood-milk barrier during lipopolysaccharide- and lipoteichoic acid-induced mastitis in dairy cows. J Dairy Sci. 2016;99(9):7544–53.PubMedCrossRef
58.
Zurück zum Zitat Lu H, Xu X, Fu D, et al. Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis. Cell Host Microbe. 2022;30(8):1139-1150.e1137.PubMedCrossRef Lu H, Xu X, Fu D, et al. Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis. Cell Host Microbe. 2022;30(8):1139-1150.e1137.PubMedCrossRef
59.
Zurück zum Zitat Okumura S, Konishi Y, Narukawa M, et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat Commun. 2021;12(1):5674.PubMedPubMedCentralCrossRef Okumura S, Konishi Y, Narukawa M, et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat Commun. 2021;12(1):5674.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Islam SMS, Ryu HM, Sayeed HM, et al. Eubacterium rectale attenuates HSV-1 induced systemic inflammation in mice by inhibiting CD83. Front Immunol. 2021;12: 712312.PubMedPubMedCentralCrossRef Islam SMS, Ryu HM, Sayeed HM, et al. Eubacterium rectale attenuates HSV-1 induced systemic inflammation in mice by inhibiting CD83. Front Immunol. 2021;12: 712312.PubMedPubMedCentralCrossRef
61.
62.
Zurück zum Zitat Kesim B, Ülger ST, Aslan G, et al. Amplicon-based next-generation sequencing for comparative analysis of root canal microbiome of teeth with primary and persistent/secondary endodontic infections. Clin Oral Investig. 2023;27(3):995–1004.PubMedCrossRef Kesim B, Ülger ST, Aslan G, et al. Amplicon-based next-generation sequencing for comparative analysis of root canal microbiome of teeth with primary and persistent/secondary endodontic infections. Clin Oral Investig. 2023;27(3):995–1004.PubMedCrossRef
64.
Zurück zum Zitat Wang Y, Nan X, Zhao Y, et al. Rumen microbiome structure and metabolites activity in dairy cows with clinical and subclinical mastitis. J Anim Sci Biotechnol. 2021;12(1):36.PubMedPubMedCentralCrossRef Wang Y, Nan X, Zhao Y, et al. Rumen microbiome structure and metabolites activity in dairy cows with clinical and subclinical mastitis. J Anim Sci Biotechnol. 2021;12(1):36.PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Barker M, Adelson P, Peters MDJ, et al. Probiotics and human lactational mastitis: a scoping review. Women Birth. 2020;33(6):e483–91.PubMedCrossRef Barker M, Adelson P, Peters MDJ, et al. Probiotics and human lactational mastitis: a scoping review. Women Birth. 2020;33(6):e483–91.PubMedCrossRef
67.
Zurück zum Zitat Li X, Xie Q, Huang S, et al. Digestion and fermentation characteristics of sulfated polysaccharides from Gracilaria chouae using two extraction methods in vitro and in vivo. Food Res Int. 2021;145: 110406.PubMedCrossRef Li X, Xie Q, Huang S, et al. Digestion and fermentation characteristics of sulfated polysaccharides from Gracilaria chouae using two extraction methods in vitro and in vivo. Food Res Int. 2021;145: 110406.PubMedCrossRef
68.
Zurück zum Zitat Sandri M, Dal Monego S, Conte G, et al. Raw meat based diet influences faecal microbiome and end products of fermentation in healthy dogs. BMC Vet Res. 2017;13(1):65.PubMedPubMedCentralCrossRef Sandri M, Dal Monego S, Conte G, et al. Raw meat based diet influences faecal microbiome and end products of fermentation in healthy dogs. BMC Vet Res. 2017;13(1):65.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Liu Q, Liu J, Roschmann KIL, et al. Histone deacetylase inhibitors up-regulate LL-37 expression independent of toll-like receptor mediated signalling in airway epithelial cells. J Inflamm (Lond). 2013;10(1):15.PubMedCrossRef Liu Q, Liu J, Roschmann KIL, et al. Histone deacetylase inhibitors up-regulate LL-37 expression independent of toll-like receptor mediated signalling in airway epithelial cells. J Inflamm (Lond). 2013;10(1):15.PubMedCrossRef
70.
Zurück zum Zitat Wang J, Wei Z, Zhang X, et al. Propionate protects against lipopolysaccharide-induced mastitis in mice by restoring blood-milk barrier disruption and suppressing inflammatory response. Front Immunol. 2017;8:1108.PubMedPubMedCentralCrossRef Wang J, Wei Z, Zhang X, et al. Propionate protects against lipopolysaccharide-induced mastitis in mice by restoring blood-milk barrier disruption and suppressing inflammatory response. Front Immunol. 2017;8:1108.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Wang JJ, Wei ZK, Zhang X, et al. Butyrate protects against disruption of the blood-milk barrier and moderates inflammatory responses in a model of mastitis induced by lipopolysaccharide. Br J Pharmacol. 2017;174(21):3811–22.PubMedPubMedCentralCrossRef Wang JJ, Wei ZK, Zhang X, et al. Butyrate protects against disruption of the blood-milk barrier and moderates inflammatory responses in a model of mastitis induced by lipopolysaccharide. Br J Pharmacol. 2017;174(21):3811–22.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Zhao C, Bao L, Qiu M, et al. Commensal cow Roseburia reduces gut-dysbiosis-induced mastitis through inhibiting bacterial translocation by producing butyrate in mice. Cell Rep. 2022;41(8): 111681.PubMedCrossRef Zhao C, Bao L, Qiu M, et al. Commensal cow Roseburia reduces gut-dysbiosis-induced mastitis through inhibiting bacterial translocation by producing butyrate in mice. Cell Rep. 2022;41(8): 111681.PubMedCrossRef
Metadaten
Titel
The cause and effect of gut microbiota in development of inflammatory disorders of the breast
verfasst von
Yibo Gu
Muye Hou
Jinyu Chu
Li Wan
Muyi Yang
Jiemiao Shen
Minghui Ji
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
European Journal of Medical Research / Ausgabe 1/2023
Elektronische ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01281-6

Weitere Artikel der Ausgabe 1/2023

European Journal of Medical Research 1/2023 Zur Ausgabe